PCN278 EXPLORING PRE AND POST AGENZIA ITALIANA DEL FARMACO (AIFA) REIMBURSED ACCESS TO IMMUNOTHERAPY FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)

Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.473
https://www.valueinhealthjournal.com/article/S1098-3015(19)32851-7/fulltext
Section Title :
Section Order : 10401
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32851-7&doi=10.1016/j.jval.2019.09.473
HEOR Topics :
Tags :
Regions :